Hospital News and Research

RSS

DISH should be considered an important cause of dysphagia among older adults: Study

Diffuse idiopathic skeletal hyperostosis is a common but often unrecognized systemic disorder observed mainly in elderly people. All papers related to DISH demonstrate a consistent and marked increase of the disease with advancing age. Various local structural lesions such as oropharyngeal tumors, vascular pathologies, retropharyngeal abscesses, and anterior cervical osteophytes may lead to mechanical esophageal dysphagia.

9 Apr 2010

Critical experts introduce mild exercise programs to care critically ill patients in ICU

A new report from critical care experts at Johns Hopkins shows that use of prescription sedatives goes down by half so that mild exercise programs can be introduced to the care of critically ill patients in the intensive care unit.

9 Apr 2010

New CMS dashboard powered by MicroStrategy

MicroStrategy® Incorporated, a leading worldwide provider of business intelligence software, today announced that the new information dashboard recently launched by the Centers for Medicare & Medicaid Services is powered by MicroStrategy.

9 Apr 2010

Hospitalists shape the future of American healthcare system

On March 21, 2010, Congress passed the most comprehensive healthcare reform bill since the formation of Medicare. While a monumental achievement, the bill leaves much of the critical work of healthcare reform unfinished, according to a new editorial by Dr. Robert Wachter, Chief of the Division of Hospital Medicine, University of California, San Francisco, and past president of the Society of Hospital Medicine, in the April issue of the Journal of Hospital Medicine.

9 Apr 2010

Tβ4 therapy for ocular disorders closer to reality

RegeneRx Biopharmaceuticals, Inc. announced today that Tβ4, a synthetic version of a naturally occurring peptide that is the basis for the company's product candidates, will be the subject of three poster presentations at the annual meeting of the Association for Research in Vision and Ophthalmology (ARVO) to be held in Fort Lauderdale, Florida from May 2-6, 2010.

9 Apr 2010

Cordis commences enrollment in safety trial of INCRAFT stent graft system for AAA

Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technologies, announced today that the first patients have been enrolled in the INNOVATION trial, which will assess the safety of a new stent graft system, called INCRAFT™, to treat abdominal aortic aneurysm (AAA). An estimated 27 million people worldwide have abdominal aortic aneurysms.

9 Apr 2010

Clarian Health Partners selects MedVentive as technology partner

Clarian Health Partners, Indiana's largest healthcare system, has selected MedVentive as a technology partner for its clinically-integrated network, Clarian Quality Partners.

9 Apr 2010

New methodology helps investigate unfolding of DNA

NYU Langone Medical Center researchers have developed a powerful new method to investigate the discrete steps necessary to turn on individual genes and examine how the process goes wrong in cancer and other diseases. The finding, based on seven years of research and described in the April 9 issue of Molecular Cell, allows scientists to investigate the unfolding of DNA, a process required for gene activation.

9 Apr 2010

Independent management of diabetes a huge issue for teens

It is hard enough being a teenager − or the parent of a teenager − without also having to deal with type 1 diabetes. Keeping good control can be a problem when the responsibility for administering insulin and checking blood glucose levels passes from parent to child.

9 Apr 2010

Scientist develops SAMON system to diagnose apnea-hypopnea sleep syndrome

The sleep study or test is key for diagnosing apnea-hypopnea syndrome but, given its high cost, few resources are earmarked to it. Computer scientist at the University of the Basque Country, Mr Alfredo Burgos, has presented a thesis that aims to solve this problem.

9 Apr 2010

Zeria to market, distribute, and sell HemCon's wound and oral care dressings in Japan

HemCon Medical Technologies, Inc., an innovative developer of advanced medical products, is proud to announce the signing of an exclusive licensing agreement with Zeria Pharmaceuticals Co. Ltd., a leading pharmaceutical and consumer healthcare products company. Through this partnership, Zeria will market, distribute, and sell HemCon's line of revolutionary wound and oral care dressings throughout Japan.

9 Apr 2010

World's largest autism science and advocacy organization awards 16 new research grants

Autism Speaks, the world's largest autism science and advocacy organization, today announced the awarding of 16 new research grants totaling $5,223,743 over the next three years.

9 Apr 2010

Five-year, $3.7M trial evaluates customized warfarin dosage based on patient genetics

A five-year, $3.7 million clinical trial will investigate how to balance the benefits and risks of warfarin, a drug that helps prevent potentially deadly blood clots.

9 Apr 2010

Six EDs across New York begin using Rochester RHIO

Axolotl Corp., the nationwide leader in health information exchange (HIE) solutions and services and Rochester RHIO, the regional health information organization connecting medical providers across nine counties in New York, today announced that six emergency departments are using Rochester RHIO to view critical patient information from data providers across the region. Emergency departments (ED) include Clifton Springs, F.F. Thompson, Lakeside Memorial, Rochester General, United Memorial Medical Center, and Wyoming Community Hospitals.

9 Apr 2010

Wolters Kluwer Health agrees to provide access to Martindale: The Complete Drug Reference

Wolters Kluwer Health, a leading global provider of information for healthcare professionals and students, has announced an agreement to provide access to Martindale: The Complete Drug Reference as part of premium subscriptions to its flagship drug reference, Facts & Comparisons® eAnswers.

9 Apr 2010

IFN therapy for chronic hepatitis C must be individualized and optimized for efficacy

The efficacy of interferon (IFN) therapy depends on the hepatitis C virus (HCV) genotype, pretreatment viral load and early viral kinetics. Thus, IFN therapy must be individualized and optimized according to the virological and clinical status of each patient.

9 Apr 2010

"Nanovaccine" reverses diabetes

A new study, published online April 8 by Cell Press in the journal Immunity, describes a unique therapeutic "nanovaccine" that successfully reverses diabetes in a mouse model of the disease. In addition to providing new insight into diabetes, the research also reveals an aspect of the pathogenesis of the autoimmune response that may provide a therapeutic strategy for multiple autoimmune disorders.

9 Apr 2010

Blood levels of carbon dioxide may be linked to near death experiences after heart attack

Near death experiences have often been described as “seeing life flash before one’s eyes” or “intense feelings of joy and peace.” Now researchers claim that levels of Carbon Dioxide or CO2 may be the causal link for these sensations. They believe that the CO2 alters the levels of certain chemicals in the brain and makes it see lights at the ends of tunnels or dead loved ones.

9 Apr 2010

English language test for foreign doctors in EU “a matter of extreme urgency”

The European commission is working on changing the existing EU laws that allow the free movement of labour especially regarding health care personnel since the regulators have raised the issue of patient safety. The issue here is mandatory English language tests for all foreign doctors working in the UK.

9 Apr 2010

Idaho man fourth in country to receive Levacor- VAD implant

After receiving only the fourth U.S. implant of a new-generation, Utah-made ventricular assist (VAD ) device, an Idaho man with heart failure is looking forward to resuming an active life following an operation on March 17 at University of Utah Hospital.

9 Apr 2010

Hospital News and Research

DISH should be considered an important cause of dysphagia among older adults: Study

Critical experts introduce mild exercise programs to care critically ill patients in ICU

New CMS dashboard powered by MicroStrategy

Hospitalists shape the future of American healthcare system

Tβ4 therapy for ocular disorders closer to reality

Cordis commences enrollment in safety trial of INCRAFT stent graft system for AAA

Clarian Health Partners selects MedVentive as technology partner

New methodology helps investigate unfolding of DNA

Independent management of diabetes a huge issue for teens

Scientist develops SAMON system to diagnose apnea-hypopnea sleep syndrome

Zeria to market, distribute, and sell HemCon's wound and oral care dressings in Japan

World's largest autism science and advocacy organization awards 16 new research grants

Five-year, $3.7M trial evaluates customized warfarin dosage based on patient genetics

Six EDs across New York begin using Rochester RHIO

Wolters Kluwer Health agrees to provide access to Martindale: The Complete Drug Reference

IFN therapy for chronic hepatitis C must be individualized and optimized for efficacy

"Nanovaccine" reverses diabetes

Blood levels of carbon dioxide may be linked to near death experiences after heart attack

English language test for foreign doctors in EU “a matter of extreme urgency”

Idaho man fourth in country to receive Levacor- VAD implant

Breathing New Life into Diagnostics: Plasmion's SICRIT Technology

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Latest News